CD274 and sarcoma: However, the bioclinical relevance of PD‐1 and PD‐L1 (e.g., prognostic value) remains controversial in sarcomas, mainly due to their high heterogeneity (Fujii et al, 2014; Nduom et al, 2016; Nowicki et al, 2017).